MKI67 and breast carcinoma: Similarly, luminal B breast cancer, defined by Ki67 ≥ 14%, is a well-recognized subtype with worse prognosis compared to luminal A [26,27], and patients with high post-treatment Ki67 levels have been shown to be at higher risk of recurrence and death compared with patients with low Ki67 levels [28].